Last reviewed · How we verify
NCT05755607
A Multicenter Prospective Randomized Controlled Study of RPD Versus LPD
NA trial testing laparoscopic pancreaticoduodenectomy in Pancreatic Cancer in 200 participants. Not yet recruiting.
1 June 2028
Quick facts
| Lead sponsor | The First Affiliated Hospital of University of South China |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 1 June 2023 |
| Primary completion | 1 June 2028 |
| Estimated completion | 1 July 2031 |
Drugs / interventions tested
- laparoscopic pancreaticoduodenectomy
- Robot Pancreaticoduodenectomy
Conditions studied
- Pancreatic Cancer — all drugs for Pancreatic Cancer →
- Common Bile Duct Diseases — all drugs for Common Bile Duct Diseases →
- Periampullary Carcinoma — all drugs for Periampullary Carcinoma →
Sponsor
The First Affiliated Hospital of University of South China
Who can join
18 and older, any sex, with Pancreatic Cancer or Common Bile Duct Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
laparoscopic pancreaticoduodenectomy(LPD) and Robot Pancreaticoduodenectomy (RPD), as two minimally invasive methods of pancreaticoduodenectomy(PD), have obvious advantages over traditional open pancreaticoduodenectomy(OPD) in terms of reducing surgical trauma and hospitalization time, but there are few studies on their perioperative safety and prognostic effects.However, there are few studies on the perioperative safety and prognostic effects of both procedures. In this trial, the perioperative data and prognosis of both procedures were collected and analyzed through a prospective, multicenter approach to investigate the advantages and disadvantages of both procedures.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05755607
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of laparoscopic pancreaticoduodenectomy
Trials testing the same drug.
- NCT06128603 — Analysis of Intraoperative Bleeding Characteristics in Laparoscopic Pancreaticoduodenectomy · unknown
- NCT06172062 — Establishment and Application of an Artificial Intelligence Algorithm for Automatic Identification of Intraoperative Ble · unknown
Other recruiting trials for Pancreatic Cancer
Currently open trials in the same condition.
- NCT07126158 — Stereotactic Body Radiotherapy Plus FAK and RAF/MEK Inhibition in Advanced Pancreatic Adenocarcinoma · Phase 2 · recruiting
- NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
- NCT07439757 — AI-Powered Precision Decision-Making for Pancreatic Diseases · recruiting
- NCT07409272 — A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherap · Phase 3 · recruiting
- NCT07236177 — B-GLUCANCER2 : A Pilot Study Evaluating a New Method for Cancer Detection by Measuring the Activity of Different Glycosi · EARLY_PHASE1 · recruiting
Other The First Affiliated Hospital of University of South China trials
Trials by the same sponsor.
- NCT07147335 — The Role of Serum AKR1B10 in Early Warning of Hepatocellular Carcinoma in Cirrhosis Patients · recruiting
- NCT06979037 — Genetic Markers of Diabetic Ulcers and Personalized Treatment Targets Research · recruiting
- NCT06492811 — Efficacy and Safety of a Hydrogel Containing Cascade Catalytic Enzymes in the Treatment of Diabetic Wounds · Phase 2 · active not recruiting
- NCT05755594 — A Prospective Study on the Safety and Efficacy of Robot-assisted Pancreaticoduodenectomy · NA · not yet recruiting
- NCT05660915 — A Prospective Clinical Study Using an Artery-first Intermediate Approach in Robot-assisted Pancreaticoduodenectomy · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05755607 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The First Affiliated Hospital of University of South China
- Last refreshed: 6 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05755607.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing